The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats.
We evaluated the effect of N(G)-nitro-L-arginine-methyl-ester (l-NAME, a nitric oxide synthase [NOS] inhibitor) and L-arginine (nitric oxide substrate) on cerebral mitochondrial dysfunction (hereafter referred to as "injury") after temporary middle cerebral artery occlusion (MCAo) during halothane or etomidate anesthesia in spontaneously hypertensive rats. Sixty minutes before MCAo, rats were randomized to 1 of 5 regimens (n = 8 per group): h/control, 1.2 minimum alveolar anesthetic concentration of halothane; h/L-NAME, 1.2 minimum alveolar anesthetic concentration of halothane and L-NAME (30 mg/kg); etomidate, an electroencephalographic (EEG) burst suppression dose of etomidate; e/L-NAME, an EEG burst suppression dose of etomidate and L-NAME (30 mg/kg); or e/L-NAME/arg, an EEG burst suppression dose of etomidate, L-NAME (30 mg/kg), and L-arginine (bolus of 300 mg/kg with an infusion at 35 mg x kg(-1) x min(-1)). After 180 min of MCAo and 120 min of reperfusion, volume of injury was determined using 2,3,5-triphenytetrazolium stain. Injury volume (mm(3), mean +/- sd) was larger in the etomidate group (153 +/- 17) than the halothane anesthetized h/control group (93 +/- 16) (P < 0.05) but did not differ between the e/L-NAME (162 +/- 17) and h/L-NAME groups (155 +/- 26). Injury volume in the e/L-NAME/arg group (88 +/- 15) was not different from the h/control group (93 +/- 16) and was less than that in either the etomidate or the e/L-NAME groups (P < 0.05). The data reproduce our previous observation that, relative to a halothane-anesthetized control state, etomidate has an adverse effect on ischemic injury in the setting of temporary focal cerebral ischemia. Prior inhibition of NOS with L-NAME resulted in no difference in the volume of injury between groups receiving etomidate or halothane (162 +/- 17 versus 155 +/- 26). Administration of a large dose of L-arginine prevented the adverse effect of etomidate. The data were obtained after only 2 h of reperfusion and therefore cannot be construed as representative of final neurologic outcome. They nonetheless suggest that etomidate produces an adverse effect on mitochondrial function early in the course of focal cerebral ischemia, in part, by inhibition of NOS.
Drummond
John C
JC
*Departments of Anesthesiology, University of California, San Diego, La Jolla; †VA Medical Center, San Diego; ‡Loma Linda University, Loma Linda, California; and §Mayo Clinic College of Medicine, Rochester, Minnesota.
McKay
Lorne D
LD
Cole
Daniel J
DJ
Patel
Piyush M
PM
D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005045:Etomidate / Q000633:toxicity*; D002546:Ischemic Attack, Transient / Q000503:physiopathology*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D051381:Rats; D011918:Rats, Inbred SHR
D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester; D005045:Etomidate
Lavine SD, Masri LS, Levy ML, Giannotta SL. Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: time limitation and advantage of brain protection. J Neurosurg 1997;87:817–24.
Samaha E, Rizk T, Nohra G, et al. Temporary occlusion in surgical management of intracranial aneurysm: report of 54 cases. Neurochirurgie 1999;45:24–8.
Watson JC, Drummond JC, Patel PM, et al. An assessment of the cerebral protective effects of etomidate in a model of incomplete forebrain ischemia in the rat. Neurosurgery 1992;30:540–4.
Sano T, Patel PM, Drummond JC, Cole DJ. A comparison of the cerebral protective effects of etomidate, thiopental, and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg 1993;76:990–7.
Drummond JC, Cole DJ, Patel PM, Reynolds LW. Focal cerebral ischemia during anesthesia with etomidate, isoflurane, or thiopental: a comparison of the extent of cerebral injury. Neurosurgery 1995;37:742–9.
Wolff DJ, Datto GA, Samatovicz RA, Tempsick RA. Calmodulin-dependent nitric-oxide synthase: mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem 1993;268:9425–9.
Nebauer AE, Doenicke A, Hoernecke R, et al. Does etomidate cause haemolysis? Br J Anaesth 1992;69:58–60.
Gladwin MT, Crawford JH, Patel RP. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 2004;36:707–17.
Cole DJ, Kalichman MW, Shapiro HM, Drummond JC. The non-linear potency of sub-MAC concentrations of nitrous oxide in decreasing the anesthetic requirement of enflurane, halothane, and isoflurane. Anesthesiology 1990;73:93–9.
Irikura K, Rosenblatt S, Kontos HA, Moskowitz MA. The effect of nitric oxide synthase (NOS) inhibition on pial artery dilation produced by somatosensory stimulation and hypercapnia. J Cereb Blood Flow Metab 1993;13:S132.
Malinski T, Bailey F, Zhang ZG, Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 1993;13:355–8.
Cole DJ, Drummond JC, Osborne TN, Matsumura J. Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema. Am J Physiol 1990;259:H211–7.
Cole DJ, Schell RM, Przybelski RJ, et al. Focal cerebral ischemia in rats: effect of hemodilution with α-α cross-linked hemoglobin on CBF. J Cereb Blood Flow Metab 1992;12:971–6.
Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290–3.
Bogle RG, Whitley GS, Soo SC, et al. Effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase. Br J Pharmacol 1994;111:1257–61.
Sorrenti V, Di Giacomo C, Salerno L, et al. Inhibition of neuronal nitric oxide synthase by N-phenacyl imidazoles. Nitric Oxide 2001;5:32–8.
Ogawa K, Tanaka S, Murray PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 2001;94:668–73.
Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708–16.
Kosaka H, Uozumi M, Tyuma I. The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Radic Biol Med 1989;7:653–8.
Katsuyama SS, Cole DJ, Drummond JC, Bradley K. Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHb) in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:1–7.
Fernandez N, Garcia JL, Garcia-Villalon AL, et al. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Br J Pharmacol 1993;110:428–34.
Mayer B, Klatt P, Werner ER, Schmidt K. Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase. FEBS Lett 1994;350:199–202.
Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 1997;28:1283–8.
Jiang MH, Kaku T, Hada J, Hayashi Y. Different effects of eNOS and nNOS inhibition on transient forebrain ischemia. Brain Res 2002;946:139–47.
Veltkamp R, Rajapakse N, Robins G, et al. Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 2002;33:2704–10.
Zhang F, White J, Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 1994;14:217–26.
Kuluz JW, Prado RJ, Dietrich WD, et al. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 1993;24:2023–9.
Gidday JM, Park TS, Shah AR, Gonzales ER. Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide. Stroke 1998;29:1423–30.
Batteur-Parmentier S, Margaill I, Plotkine M. Modulation by nitric oxide of cerebral neutrophil accumulation after transient focal ischemia in rats. J Cereb Blood Flow Metab 2000;20:812–9.
Altay T, Gonzales ER, Park TS, Gidday JM. Cerebrovascular inflammation after brief episodic hypoxia: modulation by neuronal and endothelial nitric oxide synthase. J Appl Physiol 2004;96:1223–30.
Robertson SC, Brown P, Loftus CM. Effects of etomidate administration on cerebral collateral flow. Neurosurgery 1998;43:317–24.
Edelman GJ, Hoffman WE, Charbel FT. Cerebral hypoxia after etomidate administration and temporary cerebral artery occlusion. Anesth Analg 1997;85:821–5.
Hoffman WE, Charbel FT, Edelman G, et al. Comparison of the effect of etomidate and desflurane on brain tissue games and pH during prolonged middle cerebral artery occlusion. Anesthesiology 1998;88:1188–94.
White RP, Deane C, Vallance P, Markus HS. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 1998;29:467–72.
White RP, Hindley C, Bloomfield PM, et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab 1999;19:673–8.
Joshi S, Young WL, Duong H, et al. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects. Anesthesiology 2000;93:699–707.
Cole DJ, Drummond JC, Ghazal EA, Shapiro HM. A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol 1990;80:152–5.
VandeWiele B, Rubinstein E, Peacock W, Martin N. Propylene glycol toxicity caused by prolonged infusion of etomidate. J Neurosurg Anesthesiol 1995;7:259–62.
Levy ML, Aranda M, Zelman V, Giannotta SL. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1995;37:363–71.